<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR49">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Whyte</surname>
    <given-names>CS</given-names>
   </name>
   <name>
    <surname>Morrow</surname>
    <given-names>GB</given-names>
   </name>
   <name>
    <surname>Mitchell</surname>
    <given-names>JL</given-names>
   </name>
   <name>
    <surname>Chowdary</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Mutch</surname>
    <given-names>NJ</given-names>
   </name>
  </person-group>
  <article-title>Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19</article-title>
  <source>J Thromb Haemost.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1111/jth.14872</pub-id>
  <?supplied-pmid 32634856?>
  <pub-id pub-id-type="pmid">32634856</pub-id>
 </element-citation>
</ref>
